LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .3. CELL-CYCLE DEPENDENCE FOR NEGATIVE SIGNALING OF WEHI-231 B LYMPHOMA-CELLS BY ANTI-MU

被引：137

作者：

SCOTT, DW ^{[1
]}

LIVNAT, D ^{[1
]}

PENNELL, CA ^{[1
]}

KENG, P ^{[1
]}

机构：

[1] UNIV ROCHESTER,CTR CANC,EXPTL THERAPEUT UNIT,ROCHESTER,NY 14642

来源：

JOURNAL OF EXPERIMENTAL MEDICINE | 1986年 / 164卷 / 01期

关键词：

D O I：

10.1084/jem.164.1.156

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：156 / 164

页数：9

共 50 条

[41] Toosendanin Induces Cell Cycle Arrest and Apoptosis to Suppress Diffuse Large B-Cell Lymphoma Growth by Inhibiting PI3Kα/β and PLK1 Signaling
Hu, Qian
Wang, Mengyao
Chen, Meng
Wang, Jinjin
Niu, Ting
PHYTOTHERAPY RESEARCH, 2025,
[42] ACTIVATION OF THE STAT3 SIGNALING PATHWAY PREDICTS POOR SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH R-CHOP
Huang, X.
Meng, B.
Iqbal, J.
Ding, B.
Chen, Y.
Vose, J. M.
Chan, W. C.
Ye, H. B.
Fu, K.
ANNALS OF ONCOLOGY, 2011, 22 : 127 - 127
[43] Inhibition of Phosphatidylinositol 3-Kinase Is Effective to Suppress the Growth of CD20-Negative Refractory Diffuse Large B-Cell Lymphoma Cells
Nakamaki, Tsuyoshi
Fukuchi, Kunihiko
Nakashima, Hidetoshi
Ariizumi, Hirotsugu
Maeda, Takashi
Saito, Bungo
Yanagisawa, Kouji
Tomoyasu, Shigeru
Shiozawa, Eisuke
Yamochi-Onizuka, Toshiko
Ota, Hidekazu
BLOOD, 2011, 118 (21) : 1040 - 1041
[44] Tumor dormancy and cell signaling: Anti-mu-induced apoptosis in human B-lymphoma cells is not caused by an APO-1-APO-1 ligand interaction
Racila, E
Hsueh, R
Marches, R
Tucker, TF
Krammer, PH
Scheuermann, RH
Uhr, JW
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 2165 - 2168
[45] LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .5. ANTI-IG MEDIATED GROWTH-INHIBITION IS REVERSED BY PHORBOL-MYRISTATE ACETATE BUT DOES NOT INVOLVE CHANGES IN CYTOSOLIC FREE CALCIUM
SCOTT, DW
LIVNAT, D
WHITIN, J
DILLON, SB
SNYDERMAN, R
PENNELL, CA
JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY, 1987, 3 (02): : 109 - 120
[46] The role of the PI3K pathway in Anti-IgM (Anti-μ) -sensitive and -resistant B-cell lymphomas -: Failure to disengage PI3K pathway signaling confers anti-μ resistance on the CH12B cell lymphoma
Carey, GB
Tonnetti, L
Scott, DW
MOLECULAR MECHANISMS OF PROGRAMMED CELL DEATH, 2003, : 37 - 47
[47] PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells
Fen Zhu
Hui Guo
Paul D. Bates
Shanxiang Zhang
Hui Zhang
Krystle J. Nomie
Yangguang Li
Li Lu
Kaitlyn R. Seibold
Fangyu Wang
Ian Rumball
Hunter Cameron
Nguyet M. Hoang
David T. Yang
Wei Xu
Liang Zhang
Michael Wang
Christian M. Capitini
Lixin Rui
Leukemia, 2019, 33 : 2898 - 2911
[48] PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells
Zhu, Fen
Guo, Hui
Bates, Paul D.
Zhang, Shanxiang
Zhang, Hui
Nomie, Krystle J.
Li, Yangguang
Lu, Li
Seibold, Kaitlyn R.
Wang, Fangyu
Rumball, Ian
Cameron, Hunter
Hoang, Nguyet M.
Yang, David T.
Xu, Wei
Zhang, Liang
Wang, Michael
Capitini, Christian M.
Rui, Lixin
LEUKEMIA, 2019, 33 (12) : 2898 - 2911
[49] BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells
Kong, Weibo
Sender, Sina
Taher, Leila
Villa-Perez, Simon
Ma, Yixuan
Sekora, Anett
Ruetgen, Barbara C.
Brenig, Bertram
Beck, Julia
Schuetz, Ekkehard
Junghanss, Christian
Nolte, Ingo
Murua Escobar, Hugo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
[50] B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells
Secreto, Frank
Manske, Michelle
Price-Troska, Tammy
Ziesmer, Steven
Hodge, Lucy S.
Ansell, Stephen M.
Cerhan, James R.
Novak, Anne J.
LEUKEMIA & LYMPHOMA, 2014, 55 (08) : 1884 - 1892

← 1 2 3 4 5 →